|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,612.00 GBX | +1.25% |
|
+0.25% | +30.03% |
| 01:15am | U.S. FDA Clears AstraZeneca, Daiichi Sankyo Breast Cancer Drug | MT |
| 12-15 | Enhertu® plus pertuzumab approved in the US | RE |
MarketScreener Editorial Features
Search
No results for this search
Filters
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition































